Literature DB >> 27744287

Atrial fibrillation in patients undergoing transcatheter aortic valve implantation: epidemiology, timing, predictors, and outcome.

Giuseppe Tarantini1, Marco Mojoli1, Marina Urena2, Alec Vahanian2.   

Abstract

Atrial fibrillation (AF) is a common arrhythmia in patients with aortic stenosis. When these patients are treated medically or by surgical aortic valve replacement, AF is associated with increased risk of adverse events including death. Growing evidence suggests a significant impact of AF on outcomes also in patients with aortic valve stenosis undergoing transcatheter aortic valve implantation (TAVI). Conversely, limited evidence is available regarding the optimal management of this condition. This review aims to summarize prevalence, pathophysiology, prognosis, and treatment of AF in patients undergoing TAVI. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2016. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Aortic stenosis; Atrial fibrillation; TAVI

Mesh：

Substances：

Year:  2017        PMID： 27744287     DOI： 10.1093/eurheartj/ehw456

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


  27 in total

Review 1.  Challenges in Aortic Stenosis: Review of Antiplatelet/Anticoagulant Therapy Management with Transcatheter Aortic Valve Replacement (TAVR): TAVR with Recent PCI, TAVR in the Patient with Atrial Fibrillation, and TAVR Thrombosis Management.

Authors:  Matthew W Sherwood; Amit N Vora
Journal:  Curr Cardiol Rep       Date:  2018-10-11       Impact factor: 2.931

2.  Comparison of warfarin versus DOACs in patients with concomitant indication for oral anticoagulation undergoing TAVI; results from the ATLAS registry.

Authors:  Konstantinos Kalogeras; Richard J Jabbour; Neil Ruparelia; Samuel Watson; Tito Kabir; Toru Naganuma; Manolis Vavuranakis; Sunao Nakamura; Iqbal S Malik; Ghada Mikhail; Miles Dalby; Vasileios Panoulas
Journal:  J Thromb Thrombolysis       Date:  2020-07       Impact factor: 2.300

Review 3.  Antiplatelet therapy in valvular and structural heart disease interventions.

Authors:  Annunziata Nusca; Edoardo Bressi; Iginio Colaiori; Marco Miglionico; Germano Di Sciascio
Journal:  Cardiovasc Diagn Ther       Date:  2018-10

4.  Comparing anticoagulation therapy alone versus anticoagulation plus single antiplatelet drug therapy after transcatheter aortic valve implantation in patients with an indication for anticoagulation: a systematic review and meta-analysis.

Authors:  Yong Zhu; Shuai Meng; Maolin Chen; Ruofei Jia; Jing Nan; Hong Li; Huagang Zhu; Long Li; Zening Jin
Journal:  Cardiovasc Drugs Ther       Date:  2020-10-08       Impact factor: 3.727

5.  Combined transcatheter aortic valve replacement and left atrial appendage occlusion in patients ineligible for oral anticoagulation: A case series.

Authors:  Antônio Fernando Diniz Freire; Filippe Barcellos Filippini; Tiago Costa Bignoto; Pedro Henrique Ferro de Brito; Pedro Felipe Gomes Nicz; Pedro Henrique Magalhães Craveiro de Melo; Ricardo Cavalcante E Silva; Marcelo Queiroga; Henrique Barbosa Ribeiro; Arthur Guilherme Magalhães Procópio; Cristiano Guedes Bezerra; Eberhard Grube; Alexandre Abizaid; Roberto Kalil Filho; Fábio S de Brito
Journal:  J Cardiol Cases       Date:  2022-05-25

6.  Use of Direct Oral Anticoagulant and Outcomes in Patients With Atrial Fibrillation after Transcatheter Aortic Valve Replacement: Insights From the STS/ACC TVT Registry.

Authors:  Tanyanan Tanawuttiwat; Amanda Stebbins; Guillaume Marquis-Gravel; Sreekanth Vemulapalli; Andrzej S Kosinski; Alan Cheng
Journal:  J Am Heart Assoc       Date:  2021-12-31       Impact factor: 5.501

7.  Non-vitamin K oral anticoagulants versus vitamin K antagonists in post transcatheter aortic valve replacement patients with clinical indication for oral anticoagulation: A meta-analysis.

Authors:  Yi-Feng Chen; Fei Liu; Xi-Wen Li; Hou-Jing Zhang; Yi-Ge Liu; Lu Lin
Journal:  Clin Cardiol       Date:  2022-02-22       Impact factor: 3.287

8.  Incidence, pathophysiology, predictive factors and prognostic implications of new onset atrial fibrillation following transcatheter aortic valve implantation.

Authors:  Ioanna Koniari; Grigorios Tsigkas; Nikolaos Kounis; Dimitrios Velissaris; Emmanouil Chourdakis; Periklis Davlouros; George Hahalis
Journal:  J Geriatr Cardiol       Date:  2018-01       Impact factor: 3.327

9.  Sex-related differences in clinical outcomes and quality of life after transcatheter aortic valve implantation for severe aortic stenosis.

Authors:  Maciej Bagienski; Tomasz Tokarek; Agata Wiktorowicz; Artur Dziewierz; Lukasz Rzeszutko; Danuta Sorysz; Pawel Kleczynski; Dariusz Dudek
Journal:  Postepy Kardiol Interwencyjnej       Date:  2017-09-25       Impact factor: 1.426

10.  Clinical value of the 20% logistic EuroSCORE cut-off for selecting TAVI candidates: a single-centre cohort study analysis.

Authors:  Guram Imnadze; Steffen Hofmann; Michael Billion; Abbas Ferdosi; Marek Kowalski; Ehab Rajab; Karin Bramlage; Peter Bramlage; Henning Warnecke; Norbert Franz
Journal:  Open Heart       Date:  2020-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.